Welcome to the ValueWiki Allos Therapeutics, Inc. (ALTH) article! Register for free or click the "edit" link to contribute!

Allos Therapeutics, Inc. (ALTH)

This summary section needs content! Click Here to begin writing.

Have a question about Allos Therapeutics, Inc.? Ask it on the Message Board or Chat Room

Visit the Apple, Inc. page for an example of a complete article.

Today

Max

Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.^[1] Be bold!

12/01/08 4:12 pm	Allos cancer drug candidate gets FDA orphan status (AP)
12/01/08 4:12 pm	ALLOS THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (EDGAR Online)
12/01/08 4:12 pm	U.S FDA Grants Pralatrexate Orphan Drug Designation for the Treatment of Patients with Follicular Lymphoma (Business Wire)
11/25/08 8:11 am	Allos cancer drug candidate gets FDA orphan status (AP)
11/24/08 5:11 pm	UPDATE - Allos Therapeutics' cancer drug gets orphan drug status (at Reuters)
11/24/08 4:11 pm	ALLOS THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (EDGAR Online)
11/24/08 4:11 pm	U.S. FDA Grants Pralatrexate Orphan Drug Designation for the Treatment of Patients with Diffuse Large B-Cell Lymphoma (Business Wire)
11/19/08 9:11 am	Bright Spots for Investors Discussed in Wall Street Transcript Biotechnology Report (Wall Street Transcript)
11/11/08 9:11 am	ALLOS THERAPEUTICS INC Financials (EDGAR Online Financials)
11/10/08 5:11 pm	ALLOS THERAPEUTICS INC Files SEC form 8-K/A, Regulation FD Disclosure, Financial Statements and Exhibits (EDGAR Online)